Authors:
THURLIMANN B
CASTIGLIONE M
HSUSCHMITZ SF
CAVALLI F
BONNEFOI H
FEY MF
MORANT R
LOHNERT T
GOLDHIRSCH A
Citation: B. Thurlimann et al., FORMESTANE VERSUS MEGESTROL-ACETATE IN POSTMENOPAUSAL BREAST-CANCER PATIENTS AFTER FAILURE OF TAMOXIFEN - A PHASE-III PROSPECTIVE RANDOMIZED CROSS-OVER TRIAL OF 2ND-LINE HORMONAL TREATMENT (SAKK-20 90)/, European journal of cancer, 33(7), 1997, pp. 1017-1024
Authors:
THURLIMANN B
BERETTA K
BACCHI M
CASTIGLIONEGERTSCH M
GOLDHIRSCH A
JUNGI WF
CAVALLI F
SENN HJ
FEY M
LOHNERT T
Citation: B. Thurlimann et al., FIRST-LINE FADROZOLE HCI (CGS-16949A) VERSUS TAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER - PROSPECTIVE RANDOMIZED TRIAL OF THE SWISS-GROUP-FOR-CLINICAL-CANCER-RESEARCH SAKK-20 88/, Annals of oncology, 7(5), 1996, pp. 471-479